Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATOU GARY
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Machado Patrick
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gover Justin D.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GANNON STEVEN
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cannon Gillian
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Svoronos Dawn
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Von Seggern Christopher
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer AULIN SHERRY
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KENNEY CHRISTOPHER JOHN
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer EMPFIELD JAMES R.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DiFabio Andrea
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MORTIMER IAN
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GANNON STEVEN
Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(7.7%),Behzad Aghazadeh(7.7%)
Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-DRIEHAUS CAPITAL MANAGEMENT LLC(5.88%)
Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.556%),Abigail P. Johnson(7.556%)
No Data